Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Survival following traumatic thoracic compartment syndrome managed with VV-ECMO.

Amos T, Yeung M, Gooi J, Fitzgerald M.

Trauma Case Rep. 2019 Nov 19;24:100249. doi: 10.1016/j.tcr.2019.100249. eCollection 2019 Dec.

2.

The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia.

El Khoury AC, Pilon D, Morrison L, Shak N, Vermette-Laforme M, Amos TB, Kim E, Lefebvre P.

Curr Med Res Opin. 2019 Mar;35(3):395-405. doi: 10.1080/03007995.2018.1558195. Epub 2019 Jan 3.

PMID:
30526125
3.

A comparison of treatment patterns, healthcare resource utilization, and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the US.

Manjelievskaia J, Amos TB, El Khoury AC, Vlahiotis A, Cole A, Juneau P.

J Med Econ. 2018 Dec;21(12):1221-1229. doi: 10.1080/13696998.2018.1527608. Epub 2018 Oct 9.

PMID:
30238806
4.

Short-term outcome of first episode delusional disorder in an early intervention population.

Rowland T, Birchwood M, Singh S, Freemantle N, Everard L, Jones P, Fowler D, Amos T, Marshall M, Sharma V, Thompson A.

Schizophr Res. 2019 Feb;204:72-79. doi: 10.1016/j.schres.2018.08.036. Epub 2018 Sep 6.

PMID:
30195583
5.

Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis.

Pilon D, Amos TB, Kamstra R, Manceur AM, El Khoury AC, Lefebvre P.

Curr Med Res Opin. 2019 Jan;35(1):41-49. doi: 10.1080/03007995.2018.1512477. Epub 2018 Sep 5.

PMID:
30106313
6.

Draft genome assembly of the invasive cane toad, Rhinella marina.

Edwards RJ, Tuipulotu DE, Amos TG, O'Meally D, Richardson MF, Russell TL, Vallinoto M, Carneiro M, Ferrand N, Wilkins MR, Sequeira F, Rollins LA, Holmes EC, Shine R, White PA.

Gigascience. 2018 Sep 1;7(9). doi: 10.1093/gigascience/giy095.

7.

Understanding healthcare burden and treatment patterns among young adults with schizophrenia.

Huang A, Amos TB, Joshi K, Wang L, Nash A.

J Med Econ. 2018 Oct;21(10):1026-1035. doi: 10.1080/13696998.2018.1500370. Epub 2018 Jul 27.

PMID:
30001651
8.

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial.

Barnes TRE, Leeson V, Paton C, Marston L, Osborn DP, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T.

Ther Adv Psychopharmacol. 2018 Jul;8(7):185-197. doi: 10.1177/2045125318762365. Epub 2018 Mar 8.

9.

A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States.

Zhang W, Amos TB, Gutkin SW, Lodowski N, Giegerich E, Joshi K.

Clinicoecon Outcomes Res. 2018 Jun 8;10:309-320. doi: 10.2147/CEOR.S156308. eCollection 2018. Review.

10.

Duration of untreated psychosis and clinical outcomes of first episode psychosis: An observational and an instrumental variables analysis.

Sullivan SA, Carroll R, Peters TJ, Amos T, Jones PB, Marshall M, Birchwood M, Fowler D, Johnson S, Fisher HL, Major B, Rahaman N, Joyce J, Chamberlain-Kent N, Lawrence J, Moran P, Tilling K.

Early Interv Psychiatry. 2019 Aug;13(4):841-847. doi: 10.1111/eip.12676. Epub 2018 Apr 26.

PMID:
29696781
11.

Lived experiences of negative symptoms in first-episode psychosis: A qualitative secondary analysis.

Gee B, Hodgekins J, Lavis A, Notley C, Birchwood M, Everard L, Freemantle N, Jones PB, Singh SP, Amos T, Marshall M, Sharma V, Smith J, Fowler D.

Early Interv Psychiatry. 2019 Aug;13(4):773-779. doi: 10.1111/eip.12558. Epub 2018 Mar 24.

PMID:
29573562
12.

Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression.

Olfson M, Amos TB, Benson C, McRae J, Marcus SC.

J Manag Care Spec Pharm. 2018 Mar;24(3):226-236. doi: 10.18553/jmcp.2018.24.3.226.

13.

Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.

Amos TB, Tandon N, Lefebvre P, Pilon D, Kamstra RL, Pivneva I, Greenberg PE.

J Clin Psychiatry. 2018 Mar/Apr;79(2). pii: 17m11725. doi: 10.4088/JCP.17m11725.

14.

Development and Formative Evaluation of a Communication Skills Training Program for Persons with Rheumatic and Musculoskeletal Diseases.

Schöpf AC, Schlöffel M, Amos T, Thyrolf A, Lamprecht J, Mau W, Böhm P, Farin E.

Health Commun. 2019 May;34(6):680-688. doi: 10.1080/10410236.2018.1431760. Epub 2018 Feb 1.

PMID:
29388797
15.

Social recovery therapy in combination with early intervention services for enhancement of social recovery in patients with first-episode psychosis (SUPEREDEN3): a single-blind, randomised controlled trial.

Fowler D, Hodgekins J, French P, Marshall M, Freemantle N, McCrone P, Everard L, Lavis A, Jones PB, Amos T, Singh S, Sharma V, Birchwood M.

Lancet Psychiatry. 2018 Jan;5(1):41-50. doi: 10.1016/S2215-0366(17)30476-5. Epub 2017 Dec 11.

16.

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.

Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T.

Health Technol Assess. 2017 Sep;21(49):1-56. doi: 10.3310/hta21490.

17.

Cost-effectiveness of early intervention services for psychosis and fidelity to national policy implementation guidance.

Radhakrishnan M, McCrone P, Lafortune L, Everard L, Fowler D, Amos T, Freemantle N, Singh SP, Marshall M, Sharma V, Lavis A, Jones PB, Birchwood M.

Early Interv Psychiatry. 2018 Aug;12(4):747-756. doi: 10.1111/eip.12481. Epub 2017 Aug 31.

PMID:
28857431
18.

High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer.

Glenn WK, Ngan CC, Amos TG, Edwards RJ, Swift J, Lutze-Mann L, Shang F, Whitaker NJ, Lawson JS.

Infect Agent Cancer. 2017 Aug 11;12:46. doi: 10.1186/s13027-017-0157-2. eCollection 2017.

19.

Treatment persistence and hospitalization rates among patients with schizophrenia: a quasi-experiment to evaluate a patient information program.

Pilon D, Amos TB, Germain G, Lafeuille MH, Lefebvre P, Benson CJ.

Curr Med Res Opin. 2017 Apr;33(4):713-721. doi: 10.1080/03007995.2016.1277989. Epub 2017 Feb 13.

PMID:
28055336
20.

HIV-Associated Cognitive Impairment in Perinatally Infected Children: A Meta-analysis.

Phillips N, Amos T, Kuo C, Hoare J, Ipser J, Thomas KG, Stein DJ.

Pediatrics. 2016 Nov;138(5). pii: e20160893. Epub 2016 Oct 11. Review.

21.

Prevalence and management of diabetes in residential aged care facilities in north-east Victoria, Australia.

Haines HM, Bannon-Murphy H, Amos T, Krones R.

Aust Fam Physician. 2016 Dec;45(12):908-911.

22.

Small RNA interactome of pathogenic E. coli revealed through crosslinking of RNase E.

Waters SA, McAteer SP, Kudla G, Pang I, Deshpande NP, Amos TG, Leong KW, Wilkins MR, Strugnell R, Gally DL, Tollervey D, Tree JJ.

EMBO J. 2017 Feb 1;36(3):374-387. doi: 10.15252/embj.201694639. Epub 2016 Nov 11.

23.

Healthcare costs of urinary tract infections and genital mycotic infections among patients with type 2 diabetes mellitus initiated on canagliflozin: a retrospective cohort study.

Amos TB, Montejano L, Juneau P, Bolge SC.

J Med Econ. 2017 Mar;20(3):303-313. doi: 10.1080/13696998.2016.1259167. Epub 2016 Nov 28.

PMID:
27826987
24.

Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort.

Thompson A, Marwaha S, Winsper C, Everard L, Jones PB, Fowler D, Amos T, Freemantle N, Singh SP, Marshall M, Sharma V, Birchwood M.

Acta Psychiatr Scand. 2016 Oct;134(4):321-8. doi: 10.1111/acps.12623. Epub 2016 Aug 1.

PMID:
27479903
25.

Transcriptome analysis of human brain tissue identifies reduced expression of complement complex C1Q Genes in Rett syndrome.

Lin P, Nicholls L, Assareh H, Fang Z, Amos TG, Edwards RJ, Assareh AA, Voineagu I.

BMC Genomics. 2016 Jun 6;17:427. doi: 10.1186/s12864-016-2746-7.

26.

The course of negative symptom in first episode psychosis and the relationship with social recovery.

Gee B, Hodgekins J, Fowler D, Marshall M, Everard L, Lester H, Jones PB, Amos T, P Singh S, Sharma V, Freemantle N, Birchwood M.

Schizophr Res. 2016 Jul;174(1-3):165-171. doi: 10.1016/j.schres.2016.04.017. Epub 2016 Apr 28.

PMID:
27131912
27.

The Neonatal CD8+ T Cell Repertoire Rapidly Diversifies during Persistent Viral Infection.

Venturi V, Nzingha K, Amos TG, Charles WC, Dekhtiarenko I, Cicin-Sain L, Davenport MP, Rudd BD.

J Immunol. 2016 Feb 15;196(4):1604-16. doi: 10.4049/jimmunol.1501867. Epub 2016 Jan 13.

28.

Carers' and service users' experiences of early intervention in psychosis services: implications for care partnerships.

Allard J, Lancaster S, Clayton S, Amos T, Birchwood M.

Early Interv Psychiatry. 2018 Jun;12(3):410-416. doi: 10.1111/eip.12309. Epub 2016 Jan 13.

PMID:
26758476
29.

Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.

Seddon JL, Birchwood M, Copello A, Everard L, Jones PB, Fowler D, Amos T, Freemantle N, Sharma V, Marshall M, Singh SP.

Schizophr Bull. 2016 May;42(3):619-25. doi: 10.1093/schbul/sbv154. Epub 2015 Nov 4.

30.

Investigating trajectories of social recovery in individuals with first-episode psychosis: a latent class growth analysis.

Hodgekins J, Birchwood M, Christopher R, Marshall M, Coker S, Everard L, Lester H, Jones P, Amos T, Singh S, Sharma V, Freemantle N, Fowler D.

Br J Psychiatry. 2015 Dec;207(6):536-43. doi: 10.1192/bjp.bp.114.153486. Epub 2015 Aug 20.

31.

Layers of listening: qualitative analysis of the impact of early intervention services for first-episode psychosis on carers' experiences.

Lavis A, Lester H, Everard L, Freemantle N, Amos T, Fowler D, Hodgekins J, Jones P, Marshall M, Sharma V, Larsen J, McCrone P, Singh S, Smith J, Birchwood M.

Br J Psychiatry. 2015 Aug;207(2):135-42. doi: 10.1192/bjp.bp.114.146415. Epub 2015 May 21.

PMID:
25999336
32.

Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.

Ori R, Amos T, Bergman H, Soares-Weiser K, Ipser JC, Stein DJ.

Cochrane Database Syst Rev. 2015 May 10;(5):CD007803. doi: 10.1002/14651858.CD007803.pub2. Review.

PMID:
25957940
33.

Cost and effectiveness of an eye care adherence program for Philadelphia children with significant visual impairment.

Pizzi LT, Snitzer M, Amos T, Prioli KM, Steele D, Levin AV.

Popul Health Manag. 2015 Jun;18(3):223-31. doi: 10.1089/pop.2014.0090. Epub 2015 Feb 3.

PMID:
25647611
34.

Comparing time use in individuals at different stages of psychosis and a non-clinical comparison group.

Hodgekins J, French P, Birchwood M, Mugford M, Christopher R, Marshall M, Everard L, Lester H, Jones P, Amos T, Singh S, Sharma V, Morrison AP, Fowler D.

Schizophr Res. 2015 Feb;161(2-3):188-93. doi: 10.1016/j.schres.2014.12.011. Epub 2014 Dec 23.

PMID:
25541138
35.

Inappropriate prescribing in a large community-dwelling older population: a focus on prevalence and how it relates to patient and physician characteristics.

Amos TB, Keith SW, Del Canale S, Orsi P, Maggio M, Baccarini S, Gonzi G, Liu M, Maio V.

J Clin Pharm Ther. 2015 Feb;40(1):7-13. doi: 10.1111/jcpt.12212. Epub 2014 Oct 1.

PMID:
25271047
36.

Disentangling Alcohol-Related Needs Among Pre-trial Prisoners: A Longitudinal Study.

Kissell A, Taylor PJ, Walker J, Lewis E, Hammond A, Amos T.

Alcohol Alcohol. 2014 Nov;49(6):639-44. doi: 10.1093/alcalc/agu056. Epub 2014 Aug 22.

PMID:
25150166
37.

Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort study.

Marshall M, Husain N, Bork N, Chaudhry IB, Lester H, Everard L, Singh SP, Freemantle N, Sharma V, Jones PB, Fowler D, Amos T, Tomenson B, Birchwood M.

Schizophr Res. 2014 Oct;159(1):1-6. doi: 10.1016/j.schres.2014.07.005. Epub 2014 Aug 5.

PMID:
25107851
38.

Pharmacological interventions for preventing post-traumatic stress disorder (PTSD).

Amos T, Stein DJ, Ipser JC.

Cochrane Database Syst Rev. 2014 Jul 8;(7):CD006239. doi: 10.1002/14651858.CD006239.pub2. Review.

PMID:
25001071
39.

Systematic review of neuroimaging studies in vertically transmitted HIV positive children and adolescents.

Hoare J, Ransford GL, Phillips N, Amos T, Donald K, Stein DJ.

Metab Brain Dis. 2014 Jun;29(2):221-9. doi: 10.1007/s11011-013-9456-5. Epub 2013 Dec 12. Review.

PMID:
24338026
40.

Changes in mental state associated with prison environments: a systematic review.

Walker J, Illingworth C, Canning A, Garner E, Woolley J, Taylor P, Amos T.

Acta Psychiatr Scand. 2014 Jun;129(6):427-36. doi: 10.1111/acps.12221. Epub 2013 Nov 18. Review.

PMID:
24237622
41.

Pharmacotherapy for trichotillomania.

Rothbart R, Amos T, Siegfried N, Ipser JC, Fineberg N, Chamberlain SR, Stein DJ.

Cochrane Database Syst Rev. 2013 Nov 8;(11):CD007662. doi: 10.1002/14651858.CD007662.pub2. Review.

PMID:
24214100
42.

Pathways to violent behavior during first-episode psychosis: a report from the UK National EDEN Study.

Winsper C, Singh SP, Marwaha S, Amos T, Lester H, Everard L, Jones P, Fowler D, Marshall M, Lewis S, Sharma V, Freemantle N, Birchwood M.

JAMA Psychiatry. 2013 Dec;70(12):1287-93. doi: 10.1001/jamapsychiatry.2013.2445.

PMID:
24089149
43.

Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services.

Birchwood M, Connor C, Lester H, Patterson P, Freemantle N, Marshall M, Fowler D, Lewis S, Jones P, Amos T, Everard L, Singh SP.

Br J Psychiatry. 2013 Jul;203(1):58-64. doi: 10.1192/bjp.bp.112.125500. Epub 2013 May 23.

PMID:
23703317
44.

The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics.

Birchwood M, Lester H, McCarthy L, Jones P, Fowler D, Amos T, Freemantle N, Sharma V, Lavis A, Singh S, Marshall M.

Early Interv Psychiatry. 2014 Feb;8(1):59-67. doi: 10.1111/eip.12007. Epub 2013 Jan 24.

PMID:
23347742
45.

Comparing the accuracy of brief versus long depression screening instruments which have been validated in low and middle income countries: a systematic review.

Akena D, Joska J, Obuku EA, Amos T, Musisi S, Stein DJ.

BMC Psychiatry. 2012 Nov 1;12:187. doi: 10.1186/1471-244X-12-187. Review.

46.

Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis.

Stochl J, Croudace T, Perez J, Birchwood M, Lester H, Marshall M, Amos T, Sharma V, Fowler D, Jones PB; National Eden Study Team.

Qual Life Res. 2013 Jun;22(5):1055-63. doi: 10.1007/s11136-012-0222-7. Epub 2012 Jun 17.

PMID:
22706728
47.

Finance. Putting a price on psychiatric care.

Walker J, Amos T, Knowles P, Batson S, Craissati J.

Health Serv J. 2012 Mar 1;122(6296):22-4. No abstract available.

PMID:
22571067
48.

Service users' views of moving on from early intervention services for psychosis: a longitudinal qualitative study in primary care.

Lester H, Khan N, Jones P, Marshall M, Fowler D, Amos T, Birchwood M.

Br J Gen Pract. 2012 Mar;62(596):e183-90. doi: 10.3399/bjgp12X630070.

49.

Family caregivers' experiences of involuntary psychiatric hospital admissions of their relatives--a qualitative study.

Jankovic J, Yeeles K, Katsakou C, Amos T, Morriss R, Rose D, Nichol P, McCabe R, Priebe S.

PLoS One. 2011;6(10):e25425. doi: 10.1371/journal.pone.0025425. Epub 2011 Oct 12.

50.

Psychiatric patients' views on why their involuntary hospitalisation was right or wrong: a qualitative study.

Katsakou C, Rose D, Amos T, Bowers L, McCabe R, Oliver D, Wykes T, Priebe S.

Soc Psychiatry Psychiatr Epidemiol. 2012 Jul;47(7):1169-79. doi: 10.1007/s00127-011-0427-z. Epub 2011 Aug 24.

PMID:
21863281

Supplemental Content

Support Center